Various signaling pathways, including TGF-β, Hedgehog, WNT/β-catenin, and other, are active in CMS4 CRC cells, driving the maintenance of stemness properties and immunosuppression through signaling molecules (14). This evidence concerns the gene TGFB1 and colorectal carcinoma.